<\/p>\n
Labebet<\/strong> is a 100 mg labetalol tablet<\/strong> from a WHO-GMP certified manufacturer — non-selective beta-blocker with additional alpha-1 blockade (beta:alpha ratio ~3:1 oral, 7:1 IV). Primary use is hypertension<\/strong>; also used for angina, arrhythmia control, post-myocardial-infarction secondary prevention, and as first-line antihypertensive in pregnancy<\/strong>. Typical hypertension dose: 100 mg twice daily; titrate to 200-400 mg BID if needed (800 mg\/day usual max; up to 2,400 mg\/day in severe cases).<\/strong> Contraindicated in asthma, severe bradycardia, second\/third-degree heart block, acute decompensated heart failure, and phaeochromocytoma without prior alpha-blockade<\/strong>. Do NOT stop abruptly — taper over 1-2 weeks to avoid rebound tachycardia \/ angina \/ MI.<\/p>\n<\/div>\n \ud83d\udce6 Every order is covered by our Reshipment Assurance Policy<\/strong><\/a> \u2014 if your parcel does not arrive within 20 business days, we reship it.<\/p>\n Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging \u2014 no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor \u2014 never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.<\/p>\n Labebet is an oral tablet containing labetalol 100 mg<\/strong> from a WHO-GMP certified manufacturer, supplied in 30-180 tablets. Labetalol is a non-selective beta-blocker with additional alpha-1 blockade (beta:alpha ratio ~3:1 oral, 7:1 IV). Combined alpha-1 and non-selective beta blockade gives rapid BP-lowering without reflex tachycardia. First-line antihypertensive in pregnancy<\/strong> — one of the three “pregnancy-safe” options alongside methyldopa and nifedipine. Also the standard drug for hypertensive emergencies including preeclampsia, hypertensive crisis, and phaeochromocytoma (after alpha-blockade)<\/strong>.<\/p>\n Beta-blockers reduce blood pressure through four mechanisms:<\/p>\n Beta-blockers are moderately lipophilic<\/strong>. Plasma half-life of labetalol is 6-8 hours.<\/p>\n Adult hypertension dose:<\/strong> 100 mg twice daily; titrate to 200-400 mg BID if needed (800 mg\/day usual max; up to 2,400 mg\/day in severe cases).<\/p>\n Start low, titrate upward over 2-4 weeks to target BP (typically <140\/90 in uncomplicated hypertension; <130\/80 in diabetes, chronic kidney disease, or established cardiovascular disease). Check resting pulse before each dose-increase — do not titrate if <55 bpm.<\/p>\n Monitoring:<\/strong><\/p>\n Administration:<\/strong> swallow whole with water. Take at approximately the same time each day.<\/p>\n Discontinuation:<\/strong> NEVER stop abruptly.<\/strong> Taper over 1-2 weeks (reduce by 25-50% every 3-5 days). Abrupt discontinuation causes rebound tachycardia, worsened angina, and — in patients with coronary disease — can precipitate myocardial infarction. This is one of the most important safety points for beta-blockers.<\/p>\n Common (>5%):<\/strong><\/p>\n Less common:<\/strong> depression, reduced libido \/ erectile dysfunction, gastrointestinal upset, Raynaud-like cold intolerance, bronchospasm (more common with non-selective agents).<\/p>\n Important but uncommon:<\/strong><\/p>\n Pregnancy:<\/strong> Labetalol is the first-line antihypertensive in pregnancy<\/strong> — safer than most alternatives; no teratogenic signal; widely used for gestational hypertension and preeclampsia.<\/p>\n Breastfeeding:<\/strong> compatible (low milk transfer).<\/p>\nWhy order from MedsBase<\/h3>\n
What Is Labebet?<\/h2>\n
How Labetalol Lowers Blood Pressure<\/h2>\n
\n
Approved and Evidence-Based Uses<\/h2>\n
\n
Labebet Dosage<\/h2>\n
\n
Side Effects<\/h2>\n
\n
\n
Contraindications & Cautions<\/h2>\n
\n
Drug Interactions<\/h2>\n
\n
Beta-Blocker Class at a Glance<\/h2>\n